Dina Masi
2018
In 2018, Dina Masi earned a total compensation of $241K as Chief Financial Officer and Senior Vice President at Integrated Biopharma, a 2% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,543 |
|---|---|
| Salary | $231,434 |
| Other | $8,046 |
| Total | $241,023 |
Masi received $231.4K in salary, accounting for 96% of the total pay in 2018.
Masi also received $1.5K in option awards and $8K in other compensation.
Rankings
In 2018, Dina Masi's compensation ranked 13,500th out of 14,244 executives tracked by ExecPay. In other words, Masi earned more than 5.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,500 out of 14,244 | 5th |
Division Manufacturing | 5,459 out of 5,765 | 5th |
Major group Chemicals And Allied Products | 2,041 out of 2,128 | 4th |
Industry group Drugs | 1,748 out of 1,817 | 4th |
Industry Pharmaceutical Preparations | 1,336 out of 1,391 | 4th |
Source: SEC filing on October 28, 2019.
Masi's colleagues
We found three more compensation records of executives who worked with Dina Masi at Integrated Biopharma in 2018.
News
Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
October 28, 2024
Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
October 27, 2023
Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
October 27, 2022
Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
October 27, 2021
Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
October 28, 2019